Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Levin

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
Seminars in Oncology|June 1, 1992
The place of hydroxyurea in the treatment of primary brain tumorsV A Levin
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Chemoradiation in brain tumors: assets vs. adverse effectsV A Levin
Journal of Medicinal Chemistry|June 1, 1980
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityV A Levin
Cancer Research|May 1, 1985
Bioavailability of bromodeoxyuridine in dogs and toxicity in ratsS Phuphanich, V A Levin
Cancer Chemotherapy Reports|November 1, 1974
Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumorsV A Levin, P Kabra
Oncology (Williston Park, N.Y.)|March 1, 1993
Management of brain metastases from breast carcinomaA Flowers, V A Levin
Amino Acids|April 20, 2007
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potentialL M Shantz, V A Levin
Selective Cancer Therapeutics|January 1, 1989
Dissolution and stability of carmustine in the absence of ethanolV A Levin, E M Levin
Seminars in Oncology|March 1, 1975
Chemotherapy: the agents in current useV A Levin, C B Wilson
Cancer|May 1, 1989
Chemotherapeutic treatment of the diencephalic syndrome. A case reportM C Chamberlain, V A Levin
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
Seminars in Oncology|June 1, 1992
The place of hydroxyurea in the treatment of primary brain tumorsV A Levin
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Chemoradiation in brain tumors: assets vs. adverse effectsV A Levin
Journal of Medicinal Chemistry|June 1, 1980
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityV A Levin
Cancer Research|May 1, 1985
Bioavailability of bromodeoxyuridine in dogs and toxicity in ratsS Phuphanich, V A Levin
Cancer Chemotherapy Reports|November 1, 1974
Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumorsV A Levin, P Kabra
Oncology (Williston Park, N.Y.)|March 1, 1993
Management of brain metastases from breast carcinomaA Flowers, V A Levin
Amino Acids|April 20, 2007
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potentialL M Shantz, V A Levin
Selective Cancer Therapeutics|January 1, 1989
Dissolution and stability of carmustine in the absence of ethanolV A Levin, E M Levin
Seminars in Oncology|March 1, 1975
Chemotherapy: the agents in current useV A Levin, C B Wilson
Cancer|May 1, 1989
Chemotherapeutic treatment of the diencephalic syndrome. A case reportM C Chamberlain, V A Levin
Pageof 24